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Abstract
Background: FTO is a gene located in chromosome region 16q12.2. Recently two studies have
found associations of several single nucleotide polymorphisms (SNPs) in FTO with body mass index
(BMI) and obesity, particularly rs1421085, rs17817449, and rs9939609.
Methods: We examined these three SNPs in 583 extremely obese women with current BMI
greater than 35 kg/m2 and lifetime BMI greater than 40 kg/m2, and 544 controls who were currently
normal weight (BMI<25 kg/m2) and had never been overweight during their lifetimes.
Results: We detected highly significant associations of obesity with alleles in all three SNPs (p <
10-9). The strongest association was with rs1421085 (p = 3.04 × 10-10, OR = 1.75, CI = 1.47–2.08).
A subset of 99 cases had extremely discordant sisters with BMI<25 kg/m2. The discordant sisters
differed in allele and genotype frequencies in parallel with the overall case and control sample. The
strongest association was with rs17817449 (z = 3.57, p = 3.6 × 10-4).
Conclusion: These results suggest common variability in FTO is associated with increased obesity
risk or resistance and may in part account for differences between closely related individuals.
Background
Obesity has become the most common human disorder
and it poses a serious threat to health and quality of life
through its association with diabetes, hypertension, cardi-
ovascular disease, and cancer. Rates have been increasing
during the past century, particularly during the past two
decades, and show no sign of leveling off. The average
body mass index (BMI, weight in kg/height in m2) of the
U.S. population is well into the overweight range (BMI =
28.1 kg/m2), more than 30% of the people in the United
States are obese (BMI ≥ 30 kg/m2) and more than 64% are
overweight (BMI > 25 kg/m2)[1]. Recent predictions are
for a reduction in life expectancy and quality of life for the
next generation [2].
Recently, a genome wide association study revealed an
association with a common variant in single nucleotide
polymorphisms located in intron 1 of FTO, a gene with
previously unknown function located in chromosome
region 16q12.2 [3]. A second study found associations
with nearby SNPs[4]. The 3 primary SNPs, rs9939609 in
the Frayling et al. [3] study and rs1421085 and
rs17817449 in the Dina et al study[4], are located within
20 kb and are in strong linkage disequilibrium (LD). The
FTO association is notable because of its strength and the
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consistency of replication across several samples, both
within and between studies. For example, FTO associa-
tions with physical activity related body fat accumulation
[5] and obesity related traits [6,7] were found in studies
having large sample sizes. To date, the obesity association
has been found only in Europeans or individuals of Euro-
pean descent. FTO was not associated with obesity in Han
Chinese [8] or with six Oceanic populations [9]. Field et
al. [10] tested FTO gene variants in type 1 diabetes cases
and controls, however, no significant association was
found. The association with type II diabetes is mediated
entirely by BMI [3].
In this report we examined three SNPs to determine
whether FTO variability could distinguish between
extremely obese cases and thin controls. In addition, we
extended our investigation to examine extremely discord-
ant sister pairs, because the shared genetic background




Cases were obese women (BMI ≥ 35 kg/m2) with a life-
time BMI >40 kg/m2. Independent controls were selected
who had a current and lifetime BMI ≤ 25. All cases and
controls were non-Hispanic Caucasians. Sample charac-
teristics are summarized in Table 1. The individuals in the
samples were of approximately the same age but differed
in average BMI by 29 kg/m2. As would be expected for
extreme obesity, most cases had an early onset. The
median age at obesity onset was 12 and 90% had an onset
prior to age 26. This result is consistent with the observa-
tion of Frayling et al. [3] of an FTO association in children
as young as seven years.
All subjects in the three samples gave informed consent,
and the protocol was approved by the Committee on
Studies Involving Human Beings at the University of
Pennsylvania.
Discordant Sister Pairs
A subset of the case sample had extremely discordant sis-
ters. Characteristics of the sister pairs are presented in
Table 1. All thin sisters had BMI < 25 kg/m2 and had never
been obese (BMI ≥ 27 kg/m2), while obese sisters had BMI
≥ 35 kg/m2. The sisters were similar in age but differed
markedly in BMI by an average of 26 kg/m2. This differ-
ence is more than double the average BMI of the thin sis-
ters, making the comparison comparable in magnitude to
some animal models (Table 1). The percentage body fat of
normal weight and obese sisters were 26.41 ± 5.58 and
49.36 ± 5.18, respectively.
SNP Markers
The three SNPs, rs1421085, rs17817449, and rs9939609,
are located within 19.6 kb in intron 1 of the FTO gene and
are in strong LD (pairwise r2>0.97) based on our samples.
There are two primary haplotypes, C-G-A (42.0 %) and T-
T-T (55.5 %). The T-C-T haplotype was observed at 1.7 %
Table 1: Clinical characteristics of cases/controls and discordant sister pairs
N Minimum Maximum Mean Std. Deviation
Controls
Age 544 16 65 42.63 8.75
BMI 544 15.99 24.93 20.77 1.79
% Fat 534 7.50 40.00 23.65 5.61
Cases
Age 583 18 64 41.05 9.42
BMI 583 35.08 96.95 49.41 8.81
% Fat 529 30.70 70.70 50.01 5.92
Onset Age 462 0.1 55 13.90 9.01
Thin Sisters
Age 99 14 56 37.61 9.10
BMI 99 17.01 24.90 21.80 1.88
% Fat 81 15.10 38.40 26.41 5.58
Obese Sisters
Age 99 17 65 39.55 9.27
BMI 99 35.08 71.35 47.46 8.10
% Fat 89 37.00 58.90 49.36 5.18
Onset Age 78 1 42 14.04 8.10
Differences (Obese-Thin)
Age 99 -19.00 18.00 1.94 6.39
BMI 99 13.14 50.26 25.65 8.27
% Fat 79 6.30 40.20 23.33 7.41BMC Medical Genetics 2008, 9:4 http://www.biomedcentral.com/1471-2350/9/4
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and 5 others had very low frequencies. Pairwise linkage
disequilibrium measures used Proc Allele and haplotype
analyses the Proc Haplotype EM algorithm [11] in SAS
9.1.
Genotyping
DNA was extracted from whole blood or lymphoblastoid
cell lines using a high salt method. PCR reactions and gen-
otyping were completed using an Applied Biosystems
(ABI, Foster City, CA) TaqMan 7300 system. SNP primers
and probes were provided by ABI Assays-on-Demand.
Detailed conditions are available on request.
Statistical analyses
Descriptive statistics, allele and genotype frequencies were
calculated using SPSS 15.0. Tests of Hardy-Weinberg
(HW) equilibrium were based on a Chi Square goodness-
of-fit test programmed in Excel. The program Structure
was used to test for possible population structure. For this
purpose, more than 300 SNP markers were available for
cases, while a subset of 37 were available for both cases
and controls. Association analyses were completed using
the Case Control procedure in SAS 9.1, with the overall
association with genotype based on the Armitage trend
test and odds ratios based on allele counts, reflecting addi-
tive effects.
For discordant sister pairs, mean values for BMI and per-
cent fat were compared using one-way ANOVA and anal-
ysis of covariance used General Linear Models in SPSS
15.0. Association analyses for discordant sisters used the
sibling transmission disequilibrium test (S-TDT) [12]
Power
For the case/control comparisons, power was estimated
using parameters from the original Frayling et al. [3]
study, since that study had the largest sample size. Values
reported by Dina et al. [4] were similar. Assuming a risk
allele frequency of .45, obesity prevalence = 0.2 (BMI > 35
kg/m2), linkage disequilibrium (D') = 0.80, relative risk
(RR) = 1.67, p < .05, and additive, dominant or recessive
expression, we have greater than 80% power with 520
unpaired cases and controls, the minimum number of
individuals with genotypes. This estimate considers only
the risk for the upper extreme phenotype, and conserva-
tively assumes a population prevalence based on current
BMI>35 rather than lifetime BMI>40. Power is higher still
if risk and protection are considered in the respective tails
of the distribution (analyses not shown).
Results
Genotyping
Genotype frequencies for controls, cases and the com-
bined sample were all in Hardy-Weinberg equilibrium,
and there was no evidence of structure (analyses not
shown). Genotype and allele frequencies for cases and
controls are given in the Table 2. Obese cases have consist-
ently higher minor allele frequencies that are near or
above 0.5, while those for controls were about 0.13 lower.
The genotype frequencies were similar for controls and
thin sisters and minor allele frequencies were 9–12%
lower than their obese sibling. Significance for case-con-
trol and thin-obese sister allele frequency comparisons are
given in the right column. All reach statistical significance
except for rs1421085 in discordant sisters.
Table 2: Genotype and allele frequencies of three FTO SNPs in cases/controls and discordant sisters. Significance for case-control and 
thin-obese sister allele frequency comparisons are given in the right column. Genotype comparisons are presented in Table 3.
N Genotypes Alleles Allele Freq. Difference
rs1421085 TT TC CC T C
Controls 521 .370 .518 .111 .630 .370
Cases 523 .256 .474 .270 .493 .507 p = 3.5 × 10-10
Thin Sisters 92 .337 .554 .109 .614 .386
Obese Sisters 93 .247 .548 .204 .522 .478 p = 0.07
rs17817449 TT TG GG T G
Controls 522 .393 .496 .111 .641 .359
Cases 527 .275 .469 .256 .509 .491 p = 1.2 × 10-9
Thin Sisters 98 .347 .571 .082 .633 .367
Obese Sisters 93 .258 .516 .226 .516 .484 p = 0.02
rs9939609 TT TA AA T A
Controls 520 .398 .494 .108 .645 .355
Cases 527 .288 .459 .252 .518 .482 p = 3.7 × 10-9
Thin Sisters 98 .367 .541 .092 .638 .362
Obese Sisters 92 .272 .489 .239 .516 .484 p = 0.02BMC Medical Genetics 2008, 9:4 http://www.biomedcentral.com/1471-2350/9/4
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Association study in cases and controls
The results from the association analyses for cases and
controls are presented in Table 3. Results were highly sig-
nificant (p < 10-9) for all three SNPs. The strongest associ-
ation was with rs1421985 (p = 3.04 × 10-10, OR = 1.75, CI
= 1.47–2.08) (Table 3). Considering all 8 observed haplo-
types the overall χ2 for association with case status was
50.69 (df = 7, p = 1.07 × 10-8). For the two common hap-
lotypes C-G-A and T-T-T the values were 36.47 (df = 7, p =
1.55 × 10-9) and 36.50 (df = 7, p = 1.53 × 10-9), respec-
tively.
Association studies in extremely discordant sister pairs
Results from association analyses for discordant sister
pairs are presented in Table 4. All associations are signifi-
cant and parallel those for allele frequencies (Table 2) and
associations in cases and controls (Table 3).
Discussion
The results of this study strongly replicate and extend
those from previous reports of an association between
FTO and human obesity. The effect size was large, with
odds ratios to 1.69–1.75 in cases and controls and 1.46–
1.65 in discordant sisters. These values are similar to those
reported previously [3,4]. The consistency and strength of
the associations along with the high frequencies of the
risk alleles/haplotype among extremely obese individuals
suggest the effects of this gene, while still unknown, are
common and pervasive. Given the history of non-replica-
tions for other gene associations, the consistency and
strength of the replication is particularly notable. Moreo-
ver, because of the very large sample sizes in the original
studies [3,4] one might reasonably have expected it would
be difficult to find the association with moderate sample
sizes like those of the current study. However, the effects
are quite strong and detectible even in a relatively small
sample of discordant sisters.
Extreme sampling from both tails of the phenotypic distri-
bution is uncommon, because the screening process in
sample selection requires much more effort. However, the
increase in power to detect associations is substantial [13].
The design should select for both risk and protective vari-
ation in cases and controls, respectively The case-control
sample of the current study is a powerful one and likely
played a role in the strong replication, even though it is
only of moderate size.
The use of extremely discordant sibling pairs is particu-
larly uncommon because of the difficulty and expense in
accruing such samples. However, pairs that differ in phe-
notype can increase power to identify associations, partic-
ularly when they also differ in genotype [14]. The results
from this study indicate that FTO can have a substantial
effect on obesity risk between individuals close in age,
having similar rearing environments, and sharing half
their genes identical by descent. While the sample sizes for
discordant siblings may be too small for definitive conclu-
sions, they are highly significant, consistent with other
results, and can be particularly useful in isolating causa-
Table 4: Association analyses of extremely discordant sibling pairs.
Obese Thin Z P-value
rs1421085 TT TC CC
TT 15 6 0 2.14 p = 0.032
TC 14 32 2
C C 278
rs17817449 TT TG GG
TT 18 6 0 3.57 p = 3.6 × 10-4
TG 13 34 1
GG 2 11 8
rs9939609 TT TA AA
TT 18 7 0 3.09 p = 0.002
TA 14 30 1
AA 2 12 8
Table 3: Association studies of three FTO SNPs in cases and controls
SNP N Controls N Cases Armitage χ2 p Additive OR (CI)
Cases and controls
rs1421085 521 523 39.65 3.04 × 10-10 1.75 (1.47–2.08)
rs17817449 522 527 36.55 1.51 × 10-9 1.72 (1.44–2.05)
rs9939609 520 527 34.06 5.34 × 10-9 1.69 (1.42–2.02)BMC Medical Genetics 2008, 9:4 http://www.biomedcentral.com/1471-2350/9/4
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tive sequence variability once an overall association has
been identified.
Although the role of FTO or nearby genes in susceptibility
to obesity remains unknown, several recent studies have
begun to shed light on its function. For example, FTO is
highly expressed in hypothalamic nuclei that control eat-
ing behavior [15]. An intriguing observation is that it cat-
alyzes Fe(II)- and 2OG- dependent DNA demethylation
[15], although the role of FTO related DNA methylation
in obesity is unknown. Further studies are needed to clar-
ify the functional relationship of FTO with obesity suscep-
tibility.
Conclusion
These results suggest common variability in FTO is associ-
ated with increased obesity risk or resistance and may in
part account for differences between closely related indi-
viduals.
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